Clinic
Children's Clinic Network
Children's Clinic Network was paid $9.97M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoCHILDREN'S CLINIC NETWORK
MAPLE GROVE, MN 55369
MAPLE GROVE, MN 55369
33aNPI1013278720assigned 05/30/2012
33bProvider typePrimary Care Clinic/Center
28Total paid$9.97M
24GClaims396,543
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Minnesota
Rank by total paid#2 of 72
Median peer was paid$251K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MCCORMICK, BRENDA LU controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 76,188 | $607K | |
| 2019 | 71,897 | $1.80M | |
| 2020 | 59,673 | $1.73M | |
| 2021 | 62,172 | $2.00M | |
| 2022 | 51,771 | $1.65M | |
| 2023 | 41,974 | $1.19M | |
| 2024incomplete | 32,868 | $992K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 54,822 | 49,642 | $2.78M |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 18% | 43,294 | 41,690 | $1.77M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.4% | 13,950 | 13,058 | $937K |
| X5622 | 9.0% | 15,923 | 15,296 | $893K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.9% | 9,076 | 8,800 | $489K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.8% | 19,389 | 18,788 | $482K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.9% | 7,422 | 7,250 | $384K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 7,653 | 7,245 | $342K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 5,641 | 5,337 | $285K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.3% | 8,100 | 7,849 | $233K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 3,662 | 3,562 | $191K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.2% | 895 | 876 | $120K |
68 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.0% | 24,030 | $101K |
| 99188 | <1% | 15,821 | $96K | |
| 90461 | <1% | 8,718 | $95K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,988 | $92K |
| 92551 | <1% | 18,734 | $87K | |
| 0240U | <1% | 601 | $84K | |
| 96127 | <1% | 19,582 | $76K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,235 | $73K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 678 | $69K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 532 | $38K |
| 83655 | <1% | 2,569 | $27K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 275 | $25K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 4,455 | $24K |
| 36416 | <1% | 8,825 | $23K | |
| 99173 | <1% | 20,140 | $18K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 464 | $12K |
| 80061 | Lipid panel | <1% | 1,149 | $11K |
| 90686 | <1% | 12,153 | $11K | |
| 0071A | <1% | 275 | $10K | |
| 0072A | <1% | 252 | $10K | |
| 87634 | <1% | 141 | $10K | |
| 90651 | <1% | 1,686 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,100 | $7K |
| 96161 | <1% | 4,883 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 402 | $4K |
| 85018 | <1% | 2,052 | $4K | |
| 99460 | <1% | 87 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 41 | $3K |
| 90480 | <1% | 168 | $3K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 50 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 150 | $3K |
| 90620 | <1% | 302 | $3K | |
| 0001A | <1% | 115 | $3K | |
| 0002A | <1% | 113 | $2K | |
| 90734 | <1% | 1,206 | $2K | |
| 90474 | <1% | 824 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 296 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 46 | $2K |
| 90715 | <1% | 727 | $1K | |
| 99383 | <1% | 15 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 475 | $1K |
| 90670 | <1% | 5,555 | $1K | |
| 81003 | <1% | 446 | $674.59 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 124 | $641.78 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $488.95 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $488.95 |
| 90710 | <1% | 413 | $309.71 | |
| 94664 | <1% | 29 | $296.82 | |
| 90723 | <1% | 4,107 | $286.91 | |
| 90681 | <1% | 1,646 | $257.71 | |
| 90633 | <1% | 2,791 | $256.23 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $141.85 |
| 90656 | <1% | 451 | $110.94 | |
| 82248 | <1% | 16 | $76.86 | |
| 90647 | <1% | 4,163 | $33.63 | |
| 90672 | <1% | 32 | $29.13 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 36 | $11.93 |
| 90696 | <1% | 627 | $11.79 | |
| 96160 | <1% | 15,109 | $7.96 | |
| 90716 | <1% | 959 | $1.81 | |
| 90700 | <1% | 701 | $1.11 | |
| 90707 | <1% | 662 | $1.03 | |
| 90677 | <1% | 52 | $0.11 | |
| 91321 | <1% | 38 | $0.10 | |
| 90680 | 0% | 232 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 14 | $0.00 |
| 99381 | 0% | 14 | $0.00 | |
| 91300 | 0% | 103 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCORMICK, BRENDA LU (SR. VP AND CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Childrens Health Care | Minneapolis, MN | $99.95M |
| Childrens Health Care | Minneapolis, MN | $25.45M |
| Childrens Health Care | Minneapolis, MN | $18.63M |
| Children's Health Care | Minneapolis, MN | $17.32M |
| Childrens Health Care | Minneapolis, MN | $2.88M |
| Children's Clinic Network | Edina, MN | $2.88M |
| Children's Health Care | Minneapolis, MN | $2.50M |
| Children's Health Care | Minneapolis, MN | $2.43M |
| Children's Clinic Network | West St Paul, MN | $2.37M |
| Childrens Health Care | Minneapolis, MN | $1.96M |
| Childrens Health Care Services INC | Minnetonka, MN | $792K |
| Childrens Health Care | Minneapolis, MN | $557K |
| Children's Clinic Network | Hugo, MN | $453K |
| Children's Health Care | Minneapolis, MN | $397K |
| Children's Health Care | Minneapolis, MN | $120K |
| Childrens Health Care Services INC | Minnetonka, MN | $64K |
| Children's Health Care | Minneapolis, MN | $48K |
| Children's Health Care | Minneapolis, MN | $43K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.